Artificial Intelligence in the Service of Accurate Lung Cancer Diagnosis: A Systematic Scoping Review

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 51

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

AIMS02_548

تاریخ نمایه سازی: 29 تیر 1404

چکیده مقاله:

Background and Aims: Lung cancer is one of the most common and deadliest cancers globally, primarily due to delayed or inaccurate diagnosis. Recent advancements in artificial intelligence (AI) have introduced new opportunities to improve diagnostic precision using imaging, biomarkers, and clinical data. The aim of this scoping review is to explore current evidence on how AI contributes to the early and accurate diagnosis of lung cancer. Methods: This scoping review was conducted in ۱۴۰۳. A comprehensive search was performed in PubMed, Scopus, and Google Scholar using MeSH terms such as 'artificial intelligence,' 'lung cancer,' 'diagnosis,' and 'machine learning.' After initial screening of ۱۰۵ articles published between ۲۰۲۰ and ۲۰۲۵, ۱۵ studies met the inclusion criteria and were selected for thematic analysis. Results: The reviewed studies indicated that AI supports lung cancer diagnosis in three primary domains: A-Imaging-based diagnostics – AI models, especially deep learning and convolutional neural networks (CNNs), have been used to analyze CT scans and pathology images with high accuracy in detecting early-stage lung cancer. B-Biomarker analysis – AI systems have been applied to genomic, proteomic, and liquid biopsy data to identify diagnostic biomarkers, enhancing non-invasive diagnostic capabilities. C-Clinical decision support – AI has been employed in integrated models that combine imaging, biomarkers, and clinical records to assist in subtype classification and treatment planning, especially in distinguishing between different types of lung cancer. Conclusion: Artificial intelligence has proven valuable in improving the accuracy, speed, and non-invasiveness of lung cancer diagnosis. By leveraging imaging data, molecular biomarkers, and machine learning techniques, AI tools support clinical decision-making and enable earlier interventions. However, standardization, interpretability, and clinical integration remain essential future directions for

نویسندگان

Mohammad Alizadeh

Bachelor of Laboratory Sciences, Department of Laboratory Sciences, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran

Mohammad Bastani

Bachelor of Health Information Technology, Department of Health Information Technology, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran

Mohammad Hassan Kazemi

Department of Social Medicine, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran

Nahid Mehrabi

Assistant Professor, Department of Health Information Technology, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran

Mahdi Ghorbani

Assistant Professor, Department of Laboratory Sciences, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran